Download PDF

Other users also viewed these articles

Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study Josefina Cortés-Hernández; Carlos Marras Fernández-Cid; Jose Luis Andreu Sánchez; Jaime Calvo Alén; Angel M. García-Aparicio; Elvira Díez Álvarez; Francisco Javier Hidalgo Bermejo; Carlos Coronell; Alessandra Perna; Josep Ordi Ros;
Reumatol Clin. 2023;19:312-8
RESER/NVAN: Spanish Registry of patients with ANCA- associated vasculitis: objectives and methodology Susana Romero-Yuste; Manuel Macía; Marta Domínguez-Álvaro; Antonio Fernández-Nebro; Miquel Blasco; Javier Narváez; Gema Fernández; Íñigo Rúa-Figueroa; Desirée Luis-Rodríguez; Beatriz Ventosa;
10.1016/j.reumae.2025.501990
Role of the anti-RO/SSA antibody in patients with systemic lupus erythematosus Paula Pérez Jiménez; Laura Tío Barrera; José Luis Andréu Sánchez; Tarek Carlos Salman-Monte; Irene Carrión-Barberà;
Reumatol Clin. 2025;21: